Nox1 NADPH oxidase is necessary for late but not early myocardial ischaemic preconditioning

Cardiovascular Research

Volumn 102, Issue 1, 2014, Pages 79-87

  Jiang, Shuxia ^a   Streeter, Jennifer ^a,b   Schickling, Brandon M ^a   Zimmerman, Kathy ^a   Weiss, Robert M ^a   Miller, Francis J ^a,b,c  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ischaemic preconditioning; Myocardial infarction; NF B; Nox1; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; TUMOR NECROSIS FACTOR ALPHA; OXIDOREDUCTASE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL CULTURE; CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY OCCLUSION; CORONARY REPERFUSION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART PROTECTION; ISCHEMIC PRECONDITIONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WILD TYPE; ANIMAL; C57BL MOUSE; DISEASE MODEL; HEART INFARCTION PREVENTION; MALE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PROCEDURES;

ANIMALS; DISEASE MODELS, ANIMAL; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NADH, NADPH OXIDOREDUCTASES; NF-KAPPA B; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896960306     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu027     Document Type: Article

References (32)

1. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM. Association of perioperative myocardial ischemia with cardiac morbidity and mortalityinmen undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 1990;323:1781-1788.
2. Otani H. Ischemic preconditioning: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 2008;10:207-247.
3. Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 2011;301:H1723-H1741.
4. Mauser M, Hoffmeister HM, Nienaber C, Schaper W. Influence of ribose, adenosine, and 'AICAR' on the rate of myocardial adenosine triphosphate synthesis during reperfusion after coronary artery occlusion in the dog. Circ Res 1985;56:220-230.
5. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M et al. Delayed effectsofsublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 1993;72:1293.
6. Sun JZ, Tang XL, Park SW, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen speciesinthe genesisoflate preconditioning against myocardial stunning in conscious pigs. J Clin Invest 1996;97:562.
7. Otani H. Reactive oxygen speciesas mediatorsof signal transductioninischemic preconditioning. Antioxid Redox Signal 2004;6:449-469.
8. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997;29: 207-216.
9. Chen W, Gabel S, Steenbergen C, Murphy E. Aredox-based mechanism for cardiopro-tection induced by ischemic preconditioning in perfused rat heart. Circ Res 1995;77: 424-429.
10. Tritto I, D'Andrea D, Eramo N, Scognamiglio A, De Simone C, Violante A et al. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 1997;80:743.
11. Zhou X, Zhai X, Ashraf M. Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation 1996;93:1177-1184.
12. Xuan YT, Tang XL, Banerjee S, Takano H, Li RCX, Han H et al. Nuclear factor-{kappa} B plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res 1999;84:1095.
13. Lecour S, Rochette L, Opie L. Free radicals trigger TNF alpha-inducedcardioprotection. Cardiovasc Res 2005;65:239-243.
14. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributestooxidative stressand impaired relaxation inath-erosclerosis. Circ Res 1998;82:1298-1305.
15. Li Q, Spencer NY, Oakley FD, Engelhardt JF. Endosomal Nox2 facilitates redox-dependent induction of NFk B by TNFa. Antioxid Redox Signal 2009;11:1249-1263.
16. Lassegue B, San Martin A, Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 2012;110:1364-1390.
17. Bell RM, Cave AC, Johar S, Hearse DJ, Shah AM, Shattock MJ. Pivotal role of NOX-2-containing NADPH oxidase in early ischemic preconditioning. FASEB J 2005;19: 2037-2039.
18. Sheehan AL, Carrell S, Johnson B, Stanic B, Banfi B, Miller FJ Jr. Role for Nox1 NADPH oxidase in atherosclerosis. Atherosclerosis 2011;216:321-326.
19. Bhasin N, Cunha SR, Mudannayake M, Gigena MS, Rogers TB, Mohler PJ. Molecular basis for PP2A regulatory subunit B56alpha targeting in cardiomyocytes. Am JPhysiol Heart Circ Physiol 2007;293:H109-H119.
20. Thiel WH, Chen B, Hund TJ, Koval OM, Purohit A, Song LS et al. Proarrhythmic defects in Timothy syndrome require calmodulin kinase II. Circulation 2008;118:2225-2234.
21. Hill JA, Karimi M, Kutschke W, Davisson RL, Zimmerman K, Wang Z et al. Cardiac hypertrophy isnotarequired compensatory responseto short-term pressure overload. Circulation 2000;101:2863-2869.
22. Stanic B, Katsuyama M, Miller FJ Jr. An oxidized extracellular oxidation-reduction state increases Nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation. Arterioscler Thromb Vasc Biol 2010;30:2234-2241.
23. Miller FJ Jr, Filali M, Huss GJ, Stanic B, Chamseddine A, Barna TJ et al. Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and Cl C-3. Circ Res 2007;101:663-671.
24. Dawn B, Guo Y, Rezazadeh A, Wang OL, Stein AB, Hunt Get al. Tumornecrosis factor-alpha does not modulate ischemia/reperfusion injury in naive myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol 2004;37:51-61.
25. Matsuno K, Iwata K, Matsumoto M, Katsuyama M, Cui W, Murata A et al. NOX1/NADPH oxidase is involved in endotoxin-induced cardiomyocyte apoptosis. Free Radic Biol Med 2012;53:1718-1728.
26. Tang XL, Takano H, Rizvi A, Turrens JF, Qiu Y, Wu WJ et al. Oxidant species trigger late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol Heart Circ Physiol 2002;282:H281.
27. Lecour S, Smith RM, Woodward B, Opie LH, Rochette L, Sack MN. Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection. J Mol Cell Cardiol 2002;34:509-518.
28. Flaherty MP, Guo Y, Tiwari S, Rezazadeh A, Hunt G, Sanganalmath SK et al. The role of TNF-receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning. J Mol Cell Cardiol 2008;45:735.
29. Matsuda JJ, Filali MS, Moreland JG, Miller FJ, Lamb FS. Activation of swelling-activated chloride current by tumor necrosis factor-alpha requires Cl C-3-dependent endosomal reactive oxygen production. J Biol Chem 2010;285:22864-22873.
30. Lamb FS, Moreland JG, Miller FJ Jr. Electrophysiology of reactive oxygen production in signaling endosomes. Antioxid Redox Signal 2009;11:1335-1347.
31. Bozeat ND, Xiang SY, Ye LL, Yao TY, Duan ML, Burkin DJ et al. Activationofvolumeregu-lated chloride channels protects myocardium from ischemia/reperfusion damage in second-window ischemic preconditioning. Cell Physiol Biochem 2011;28:1265-1278.
32. Muzaffar S, Shukla N, Massey Y, Angelini GD, Jeremy JY. NADPH oxidase 1 mediates upregulation ofthromboxane A2synthaseinhuman vascular smooth muscle cells: inhibition with iloprost. Eur J Pharmacol 2011;658:187-192.